Publication:
Severe malaria is associated with a deficiency of von Willebrand factor cleaving protease, ADAMTS13

dc.contributor.authorEster C. Löwenbergen_US
dc.contributor.authorPrakaykaew Charunwatthanaen_US
dc.contributor.authorSophie Cohenen_US
dc.contributor.authorBert Jan Van Den Bornen_US
dc.contributor.authorJoost C.M. Meijersen_US
dc.contributor.authorEmran B. Yunusen_US
dc.contributor.authorMahtab U. Hassanen_US
dc.contributor.authorGofranul Hoqueen_US
dc.contributor.authorRichard J. Maudeen_US
dc.contributor.authorForradee Nuchsongsinen_US
dc.contributor.authorMarcel Levien_US
dc.contributor.authorArjen M. Dondorpen_US
dc.contributor.otherAcademic Medical Centre, University of Amsterdamen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherChittagong Medical College Hospitalen_US
dc.contributor.otherNuffield Department of Clinical Medicineen_US
dc.date.accessioned2018-09-24T09:38:27Z
dc.date.available2018-09-24T09:38:27Z
dc.date.issued2010-01-01en_US
dc.description.abstractSevere falciparum malaria remains a major killer in tropical countries. Central in the pathophysiology is mechanical obstruction in the microcirculation caused by cytoadherence and sequestration of parasitized erythrocytes. However, the pathogenesis of many features complicating severe malaria, including coma, renal failure and thrombocytopenia, remains incompletely understood. These disease manifestations are also key features of thrombotic thrombocytopenic purpura, a life-threatening disease strongly associated with a deficiency of the von Willebrand factor (VWF) cleaving protease, ADAMTS13. We measured plasma ADAMTS13 activity, VWF antigen and VWF propeptide levels in 30 patients with severe falciparum malaria, 12 patients with uncomplicated falciparum malaria and 14 healthy Bangladeshi controls. In patients with severe malaria ADAMTS13 activity levels were markedly decreased in comparison to normal controls (mean [95%CI]: 23% [20-26] vs. 64% [55-72]) and VWF antigen and propeptide concentrations were significantly elevated (VWF antigen: 439% [396-481] vs. 64% [46-83]; VWF propeptide: 576% [481-671] vs. 69% [59-78]). In uncomplicated malaria VWF levels were also increased compared to healthy controls but ADAMTS13 activity was normal. The results suggest that decreased ADAMTS13 activity in combination with increased VWF concentrations may contribute to the complications in severe malaria. © Schattauer 2010.en_US
dc.identifier.citationThrombosis and Haemostasis. Vol.103, No.1 (2010), 181-187en_US
dc.identifier.doi10.1160/TH09-04-0223en_US
dc.identifier.issn03406245en_US
dc.identifier.other2-s2.0-74249118600en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/29883
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=74249118600&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleSevere malaria is associated with a deficiency of von Willebrand factor cleaving protease, ADAMTS13en_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=74249118600&origin=inwarden_US

Files

Collections